Yazar "Yenerçağ, Mustafa" için listeleme
-
Angiotensin receptor neprilysin inhibitor for patients with heart failure and reduced ejection fraction: Real-world experience from Turkey (ARNi-TR)
Ekici, Berkay; Yaman, Mehmet; Küçük, Murathan; Dereli, Seçkin; Yenerçağ, Mustafa; Yiğit, Zerrin; Baş, Mehmet Memduh; Karavelioğlu, Yusuf; Çakmak, Hüseyin Altuğ; Kıvrak, Tarık; Özkan, Hakan; Altın, Cihan; Şabanoğlu, Cengiz; Demirkan, Burcu; Ataş, Ali Ekber; Kılıçaslan, Fethi; Altay, Hakan; Tengiz, İstemihan; Erkan, Aycan Fahri; Kılıçaslan, Barış; Olgun, Fatih Erkam; Durakoğlugil, Murtaza Emre; Alhan, Aslıhan; Zoghi, Mehdi (AVES, 2021)Objective: Heart failure (HF) is a growing public health problem with high morbidity and mortality. Recently, angiotensin receptor neprilysin inhibitor (ARNi) has emerged as a promising treatment for HF with reduced ejection ... -
Modified model for end-stage liver disease score predicts 30-day mortality in high-risk patients with acute pulmonary embolism admitted to intensive care units
İdin, Kadir; Dereli, Seçkin; Kaya, Ahmet; Yenerçağ, Mustafa; Yılmaz, Ahmet Seyda; Tayfur, Kaptanıderya; Gülcü, Oktay (Modified model for end-stage liver disease score predicts 30-day mortality in high-risk patients with acute pulmonary embolism admitted to intensive care units, 2021)Objectives The Model for End-stage Liver Disease excluding the international normalised ratio that is derived from prothrombin time which is calculated as a ratio of the patient's prothrombin time to a control prothrombin ... -
Modified model for end-stage liver disease score predicts 30-day mortality in high-risk patients with acute pulmonary embolism admitted to intensive care units
İdin, Kadir; Dereli, Seçkin; Kaya, Ahmet; Yenerçağ, Mustafa; Yılmaz, Ahmet Seyda; Tayfur, Kaptanıderya; Gülcü, Oktay (Taylo & Francis Ltd., 2021)Objectives The Model for End-stage Liver Disease excluding the international normalised ratio that is derived from prothrombin time which is calculated as a ratio of the patient's prothrombin time to a control prothrombin ... -
Rationale, design, and methodology of the MORCOR-TURK trial: predictors of in-hospital MORtality in CORonary care patients in Turkey
Kahraman, Fatih; Ersoy, İbrahim; Yılmaz, Ahmet Seyda; Atıcı, Adem; Tekin, Alpin Mert; Açar, Burak; Kaya, Çağlar; Kara, Faruk; Kurt, Feyza; Çerik, İdris Buğra; Yılmaz, İshak; Adalı, Mehmet Koray; Yeni, Mehtap; Taşcanov, Mustafa Beğenç; Yenerçağ, Mustafa; Şahin, Mürsel; Duz, Ramazan; Gülaştı, Sevil; Ömür, Sefa; Hidayet, Siho; Kaçmaz, Yücel; Aygül, Nazif (2023)Background: Coronary care units are sophisticated clinics established to reduce deaths due to acute cardiovascular events. Current data on coronary care unit mortality rates and predictors of mortality in Turkey are very ...